Application of pharmaceutical composition in preparing medicine for treating community-acquired pneumonia

Abstract

The invention belongs to the technical field of medicines, and in particular relates to application of a pharmaceutical composition in preparing a medicine for treating community-acquired pneumonia. The pharmaceutical composition consists of the following components: radix pseudostellariae, astragalus membranaceus, radix ophiopogonis, radix polygonati officinalis, conic gymnadenia tuber, prepared rehmannia root, radix trichosanthis, scutellaria baicalensis, oldenlandia diffusa and liquorice root. The pharmaceutical composition disclosed by the invention, which is totally prepared from Chinese herbal medicines, has functions of benefiting qi and strengthening body resistance, nourishing blood and promoting secretion of saliva; the pharmaceutical composition is consistent with the symptom of the community-acquired pneumonia and especially on community-acquired pneumonia caused by deficiency of both qi and yin, and the pharmaceutical composition is significant in curative effect.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to the use of a pharmaceutical composition in the preparation of medicines for treating community-acquired pneumonia. Background technique [0002] Community-acquired pneumonia in traditional Chinese medicine belongs to the syndromes of "wind-warm", "winter-warm" and "pulmonary-heat" in exogenous febrile diseases. Wind-warm lung-heat disease is caused by wind-heat pathogens invading the lungs, heat obstructing lung qi, and loss of clearing of the lungs. The main clinical manifestations are fever, cough, and chest pain. It is equivalent to acute pulmonary inflammatory disease, belongs to the research field of exogenous diseases and syndromes in TCM internal medicine, and is a common and frequently-occurring disease in TCM internal medicine. [0003] At present, Western medicine mainly uses the second and third generation cephalosporins, β-lactams, and fluoroquinolones ...

AI Technical Summary

Problems solved by technology

[0003] At present, Western medicine mainly uses the second and third generation cephalosporins, β-lactams, and fluoroquinolones for treatment. Although they have certain curative effects, with the changes of pathogenic microorganisms, the phenomenon of drug resistance is becoming more and more serious, and the side effects are relatively large. It is expensive, so it is difficult to be widely promoted, and traditional Chinese medicine has shown great advantages in improving symptoms and signs, shortening the course of treatment and improving the overall therapeutic effect. Therefore, it is necessary to study effective traditional Chinese medicine compositions for the treatment of community-acquired pneumonia